Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4290)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Feb 21, 2024 (publication date) through Apr 15, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | He QJ, Li YF, Zhao LT, Lin CT, Yu CY, Wang D. Recent advances in age-related metabolic dysfunction-associated steatotic liver disease. World J Gastroenterol 2024; 30(7): 652-662 [PMID: 38515956 DOI: 10.3748/wjg.v30.i7.652] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v30/i7/652.htm |
| Number | Citing Articles |
| 1 |
Julia Markowska, Kamila Kasprzak-Drozd, Przemysław Niziński, Magdalena Dragan, Adrianna Kondracka, Ewa Gondek, Tomasz Oniszczuk, Anna Oniszczuk. Quercetin: A Promising Candidate for the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Molecules 2024; 29(22): 5245 doi: 10.3390/molecules29225245
|
| 2 |
Feng Zhu, Bing-Ru Lin, Shi-Hua Lin, Chao-Hui Yu, Yun-Mei Yang. Hepatic-specific vitamin D receptor downregulation alleviates aging-related metabolic dysfunction-associated steatotic liver disease. World Journal of Gastroenterology 2025; 31(14): 104117 doi: 10.3748/wjg.v31.i14.104117
Abstract(43) |
Core Tip(29) |
Full Article(HTML)(112)
|
Full Article with Cover (PDF)-34957K(13)
|
Audio-192K(1)
|
Peer-Review Report-228K(7)
|
Answering Reviewers-442K(7)
|
Supplementary Material-562K(5)
|
Full Article (PDF)-34673K(10)
|
Full Article (XML)-144K(7)
|
Times Cited (0)
|
Total Visits (341)
|
Open
|
| 3 |
Xingyu Yuan, Yifeng Hou, Narisu Qin, Lu Xiang, Zhe Jiang, Xiaolan Bao. Flaxseed-derived peptide, Ile-Pro-Pro-Phe (IPPF), ameliorates hepatic cholesterol metabolism to treat metabolic dysfunction-associated steatotic liver disease by promoting cholesterol conversion and excretion. Food & Function 2025; 16(7): 2808 doi: 10.1039/D4FO04478A
|
| 4 |
Vu Thuong Huyen, Kanae Echizen, Ryota Yamagishi, Miho Kumagai, Yoshiki Nonaka, Takahiro Kodama, Tatsuya Ando, Megumu Yano, Naoki Takada, Masaki Takasugi, Fumitaka Kamachi, Naoko Ohtani. Regular exercise suppresses steatosis‐associated liver cancer development by degrading E2F1 and c‐Myc via circadian gene upregulation. Genes to Cells 2024; 29(11): 1012 doi: 10.1111/gtc.13161
|
| 5 |
Agnieszka Ziółkiewicz, Przemysław Niziński, Jakub Soja, Tomasz Oniszczuk, Maciej Combrzyński, Adrianna Kondracka, Anna Oniszczuk. Potential of Chlorogenic Acid in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Animal Studies and Clinical Trials—A Narrative Review. Metabolites 2024; 14(6): 346 doi: 10.3390/metabo14060346
|
| 6 |
Jiaxin Zhao, Huiying Zhou, Rui Wu, Chen Ruan, Cheng Wang, Jiawei Ding, Tao Zhang, Zheyu Fang, Huilin Zheng, Lei Zhang, Jie Zhou, Zhenhua Hu. Biological aging accelerates hepatic fibrosis: Insights from the NHANES 2017–2020 and genome-wide association study analysis. Annals of Hepatology 2025; 30(2): 101579 doi: 10.1016/j.aohep.2024.101579
|